Quit Smoking Study for People Who Use E-Cigarettes

• Status: Recruiting
• Trial end date: 2023-08-01
• Target enrollment: 0
• Participant gender: All

Summary

The overarching aim of this proposed randomized controlled trial (RCT) is to test nicotine replacement therapy (NRT) with text message support for two smoking cessation approaches among young adult dual users of combustible cigarettes (CC) and electronic cigarettes (EC). The investigators will use a 2x2 factorial design to randomize 390 participants to receive A) NRT plus text messages to quit CCs only, B) NRT plus text messages to quit CCs and ECs simultaneously, C) text messages alone to quit CCs only, or D) text messages alone to quit CCs and ECs simultaneously. The investigators primary outcome will be 7-day point-prevalence abstinence at the end of treatment (i.e., 3 months after randomization). The investigators will recruit participants using national advertising strategies. All treatment will be provided remotely in order to increase treatment access and comply with current COVID-19 restrictions.

• Phase: Phase 2
• Accepts Healthy Volunteers?: Accepts Healthy Volunteers

Details

• Lead Sponsor: University of Vermont
• Treatments: Nicotine

Criteria

Inclusion criteria:

• Young adult

• Smokes tobacco cigarettes

• Uses electronic cigarettes

• Interested in quitting tobacco

Exclusion criteria:

• Pregnant or planning to become pregnant

• Breastfeeding or planning to start breastfeeding

• One or more contraindications for nicotine replacement therapy

Additional criteria will be assessed to determine eligibility.

If you are interested in participating, please visit the study website to find out if you are eligible: https://www.uvmquitsmokingstudy.org/